Similar articles for PMID: 30275210

Year	Number of Results
1958	1
1998	1
1999	1
2001	1
2002	4
2003	1
2006	1
2007	8
2008	3
2009	5
2010	5
2011	6
2012	4
2013	10
2014	1
2015	3
2016	7
2017	1
2018	3
2019	8
2020	5
2021	3
2022	1
2023	0

1

Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients.

Grabowski JP, Richter R, Rittmeister H, Chekerov R, Woopen H, Sehouli J. Grabowski JP, et al. Anticancer Res. 2018 Oct;38(10):5853-5858. doi: 10.21873/anticanres.12927. Anticancer Res. 2018. PMID: 30275210

2

Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).

Woopen H, Inci G, Richter R, Chekerov R, Ismaeel F, Sehouli J. Woopen H, et al. Eur J Cancer. 2016 Jun;60:101-6. doi: 10.1016/j.ejca.2016.03.008. Epub 2016 Apr 19. Eur J Cancer. 2016. PMID: 27104667

3

The prognostic and predictive role of pain before systemic chemotherapy in recurrent ovarian cancer: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients.

Woopen H, Richter R, Inci G, Alavi S, Chekerov R, Sehouli J. Woopen H, et al. Support Care Cancer. 2020 Apr;28(4):1997-2003. doi: 10.1007/s00520-019-05000-y. Epub 2019 Aug 5. Support Care Cancer. 2020. PMID: 31385100

4

The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).

Woopen H, Richter R, Chekerov R, Siepmann T, Ismaeel F, Sehouli J. Woopen H, et al. Gynecol Oncol. 2015 Sep;138(3):735-40. doi: 10.1016/j.ygyno.2015.07.007. Epub 2015 Jul 13. Gynecol Oncol. 2015. PMID: 26185017

5

Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.

Canaz E, Grabowski JP, Richter R, Braicu EI, Chekerov R, Sehouli J. Canaz E, et al. Gynecol Oncol. 2019 Sep;154(3):539-546. doi: 10.1016/j.ygyno.2019.06.014. Epub 2019 Jun 21. Gynecol Oncol. 2019. PMID: 31230821

6

Prognostic role of chemotherapy-induced nausea and vomiting in recurrent ovarian cancer patients: results of an individual participant data meta-analysis in 1213.

Woopen H, Richter R, Chekerov R, Inci G, Alavi S, Grabowski JP, Sehouli J. Woopen H, et al. Support Care Cancer. 2020 Jan;28(1):73-78. doi: 10.1007/s00520-019-04778-1. Epub 2019 Apr 13. Support Care Cancer. 2020. PMID: 30980260

7

Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment.

Srisuttayasathien M, Khemapech N. Srisuttayasathien M, et al. Asian Pac J Cancer Prev. 2013;14(12):7669-74. doi: 10.7314/apjcp.2013.14.12.7669. Asian Pac J Cancer Prev. 2013. PMID: 24460351 Free article.

8

A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma.

Aoki D, Katsumata N, Nakanishi T, Kigawa J, Fujiwara K, Takehara K, Kamiura S, Hiura M, Hatae M, Sugiyama T, Ochiai K, Noda K. Aoki D, et al. Jpn J Clin Oncol. 2011 Mar;41(3):320-7. doi: 10.1093/jjco/hyq192. Epub 2010 Oct 25. Jpn J Clin Oncol. 2011. PMID: 20974678 Clinical Trial.

9

Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.

Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH, Fleming GF; Gynecologic Oncology Group. Modesitt SC, et al. Gynecol Oncol. 2007 Apr;105(1):59-65. doi: 10.1016/j.ygyno.2006.10.045. Epub 2006 Dec 5. Gynecol Oncol. 2007. PMID: 17150247 Clinical Trial.

10

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.

Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA. Bamias A, et al. Oncology. 2013;84(3):158-65. doi: 10.1159/000341366. Epub 2012 Dec 28. Oncology. 2013. PMID: 23296063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year